Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Giorgio Panozzo has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reply to Mattei et al. Jacob Disease, Osteochondroma of the Coronoid Process, Coronoid Process Hyperplasia or Langenbeck Disease: The Big Jumble. Comment on “Raccampo et al. Jacob’s Disease: Case Series, Extensive Literature Review and Classification Proposal. J. Clin. Med. 2023, 12, 938”

    by Luca Raccampo, Giorgio Panozzo, Alessandro Tel, Lorenzo Trevisiol, Antonio D’agostino, Salvatore Sembronio, Massimo Robiony

    As authors of the text, we can only thank Mattei et al.


  • Open Access

    Jacob’s Disease: Case Series, Extensive Literature Review and Classification Proposal

    by Luca Raccampo, Giorgio Panozzo, Alessandro Tel, Michele Di Cosola, Gianluca Colapinto, Lorenzo Trevisiol, Antonio D’agostino, Salvatore Sembronio, Massimo Robiony

    Jacob’s disease is a rare entity consisting of the formation of a pseudojoint between an abnormal coronoid process of the mandible and the inner surface of the zygomatic bone. First described by Jacob in 1899, its diagnosis and definition have never been entirely univocal. In this paper, we present three emblematic cases and an extensive review of the literature on Jacob’s disease. Given the variability observed in the presentation of the disease, we have developed a proposal for the classification, here reported.


  • Single-Step Full-Face Surgical Treatment of the Facial Profile

    by Dario Bertossi, Luca Sacchetto, Salvatore Chirumbolo, Giorgio Panozzo, Krishan Mohan Kapoor

    The present study was performed to describe how much affordable, feasible, and straightforward is the approach the authors called “single-stage full-face surgical profileplasty,” tailored to greatly improve the surgery of the facial profiling setting and achieve complete profile correction at the same time. From January 2010 to May 2019, 113 patients (95 females and 18 males; aged 19 − 63 years) were surgically treated for full-face profile amelioration. Profile correction was performed by using a combination of five procedures out of other various previously experienced: forehead fat grafting, rhinoplasty, lip fat grafting, genioplasty, and submental liposuction. All patients were assessed at 1, 3, 6, and 12 months following surgery for assessing the surgical profile treatment (SPT) outcome and any possible side effects of the combined treatment. Facial profile stability at 1 year was taken as the completion point of this treatment. Arnett et al's “Soft Tissue Cephalometric Analysis” (1999) was used to clinically evaluate the soft tissues before and after the SPT. Patients' satisfaction was measured with the Client Satisfaction Questionnaire-8” at 3 and 12 months after surgery. Statistics were used for Arnett et al's evaluation. Almost all the values were consistent and reached the normal ranges indicated by Arnett et al (p < 0.001), confirming that the desired results of the surgical profileplasty have been achieved. Single-stage full-face surgical profile treatment helps in correcting faults of the global facial deformity, in every single treated area, providing an overall improvement in facial aesthetics and harmony. Obtaining the simultaneous correction in the whole face has also the advantage of avoiding multiple surgical procedures, reducing postoperative discomfort, and the overall risks for the patient due to multiple surgical and anesthetic procedures.


  • Open Access

    Maxillary Sinusitis as a Complication of Zygomatic Implants Placement: A Narrative Review

    by Riccardo Nocini, Giorgio Panozzo, Alessandro Trotolo, Luca Sacchetto

    Aims: The aim of this review is to consider maxillary sinusitis as a complication of zygomatic implants placements. Maxillary sinusitis a common complication but in the literature there are no reviews that focus only on this condition and its possible treatment. This review was carried out with to highlight the main findings of the literature on this topic and to improve knowledge in this field. Methods: The search strategy resulted in 155 papers. After selection of the inclusion criteria only 11 papers were examined. From the papers these, 12.3% patients presented maxillary sinusitis but only four studies evaluated sinusitis (both clinical and radiological evaluation). The most common treatment used by the authors were antibiotics alone or combined with functional endoscopic sinus surgery (FESS). Results: The literature shows an absence of precise and shared guidelines diagnosis and post-operative follow-up, and of the treatment of maxillary sinusitis following zygomatic implantology. It has not been determined if the surgical placement of ZIs is better than the other techniques for treatment of the onset of maxillary sinusitis in the post-operative period. Conclusion: To date there are no shared protocols for maxillary sinusitis treatment. In our experience, and according to the literature in the presence of risk factors such as age, comorbidities, smoking, nasal septal deviation or other anatomical variants, we suggested that FESS is performed at the same time as placement of zygomatic implants.


  • Open Access

    Dentoalveolar surgery and Prevention of Medication-related Osteonecrosis of the Jaw (MR-ONJ) in patients treated with Bisphosphonates: our experience.

    by Fabio Lonardi, Giorgia Capocasale, Francesca Zotti, Riccardo Nocini, Annarita Signoriello, Giorgio Panozzo, Massimo Albanese

    Bisphosphonates (BPs) are the most commonly used antiresorptive drugs to prevent skeletal-related events (SREs) in cancer and osteometabolic patients. A potential adverse drugs reaction associated with the administration of these drugs is Medication-related Osteonecrosis of the Jaw (MR-ONJ); its frequency in cancer patients is higher than in osteometabolic patients. Different risk factors have been identified: drug type, duration of treatment, demographic, systemic and local factors. Among the latter, the most reported and investigated are dentoalveolar surgical procedures, anatomical factors, prosthesis and associated local oral inflammatory diseases. To date, MR-ONJ pathophysiology remains unclear, therefore, definitive protocols on prevention in oral surgery have not been established yet. Several studies had investigated the procedures to prevent the occurrence of MR-ONJ after oral surgery, particularly for tooth extraction. These proposed protocols included antibiotic and mouthwash treatment, atraumatic extraction, primary closure of the extraction socket, laser biostimulation and the use of autologous platelet concentrates. The present study aimed to evaluate our one year experience in the prevention of MRONJ after dentoalveolar surgery in patients receiving bisphosphonate therapy. The protocol described and proposed by the Italian Society of Oral and Maxillofacial Surgery (SICMF) and the Italian Society of Oral Pathology and Medicine (SIPMO) has been followed; this protocol includes medical prophylaxis with strictly described surgical procedures

  • Open Access

    Prevention of Medication-related Osteonecrosis of the Jaw (MR-ONJ) after dentoalveolar surgery in cancer patients: one year experience.

    by Giorgia Capocasale, Fabio Lonardi, Annarita Signoriello, Giorgio Panozzo, Francesca Zotti, Riccardo Nocini, Massimo Albanese

    Medication-related Osteonecrosis of the Jaw (MR-ONJ) is an adverse drugs reaction characterized by the worsening of quality of life in cancer patients, and for which one of the most frequent risk factor recognized is tooth extraction. This report aims to describe our one-year experience about the prevention of MR-ONJ in cancer patients receiving antiresorptive-antiangiogenic drugs, with or without Bisphosphonates, referred to the Department of Surgical Sciences, Paediatrics and Gynaecology (University of Verona). The protocol described by the Italian Society of Oral and Maxillofacial Surgery (SICMF) and the Italian Society of Oral Pathology and Medicine (SIPMO) was strictly followed in all surgical procedures, including the defined medical prophylaxis. Once assessed inclusion and exclusion criteria, a retrospective analysis was carried out in a total of 15 patients, followed up during 2019. None of our patients developed MR-ONJ.